Redbrick AI Raises US$4.6M To Accelerate The Development Of ...| MENAFN.COM

Saturday, 10 December 2022 06:13 GMT

Redbrick AI Raises US$4.6M To Accelerate The Development Of Healthcare AI


(MENAFN- News Direct)

Michigan, US | November 23, 2022 06:00 AM Eastern Standard Time

Health-tech AI platform redbrick ai is today announcing a US$4.6M seed funding round to accelerate the development and adoption of artificial intelligence in clinical settings, through rapid data annotation on medical imagery. The round was led by Surge, Sequoia Capital India, and Southeast Asia's rapid scale-up program, with participation from Y Combinator and angels.

Medical imagery is an essential source of truth in clinical diagnosis and comprises about 90% of all healthcare data. AI systems can dramatically shorten the time to diagnosis, improve clinician productivity by triaging high-importance cases, and act as the first line of defense in under-staffed clinical environments.

Researchers and healthcare institutions are increasingly investing in AI solutions to improve diagnostics, treatment and patient quality of care. The use of AI in healthcare stands to transform patient care by boosting clinician productivity and automating clinical diagnosis. In 2021 alone, the U.S. Food and Drug Administration (FDA) approved 115 AI algorithms for use in medical environments, an 83% increase from 2018.




Annotation of a brain bleed in a brain MRI study on RedBrick AI's platform

However, researchers cannot use medical images to train AI systems until they are cleaned and expertly annotated. Training an AI system also requires hundreds of annotated medical images and thousands of hours of annotation by clinicians. Due to the complexity, size, and unique nature of medical images, clinicians have to resort to traditional and difficult-to-use clinical tools to perform annotations.




RedBrick AI is a data-labeling platform

RedBrick AI is thus laser focused on solving the first key challenge to healthcare AI adoption – providing clinicians high-quality data annotation tools that accelerate the preparation of training datasets.




RedBrick AI Founders: (L to R) Derek Lukacs and Shivam Sharma

RedBrick AI CEO and co-founder Shivam Sharma commented:“Working with leading healthcare AI teams over the past year has been an incredible journey and learning opportunity. With the rapid growth of artificial intelligence in clinical settings, researchers need excellent tools to build high-quality datasets and models at scale. Our customers are in the vanguard of this growth, pioneering everything from surgical robots to automated detection of cancers. We are incredibly excited to use the funds we've raised to power the next generation of researchers in building AI for clinical settings.”

RedBrick AI's tools address several challenges unique to medical data annotation, such as the complexity of existing annotation tools, quality control and machine learning integration. The platform's specialized annotation tools can be accessed through the browser and are designed to be used without prior training. RedBrick AI also offers semi-automated tools to annotate complex 3D medical images.

RedBrick has a robust quality control process to ensure the quality of annotations, which are crucial to securing AI algorithm certifications from regulators. It involves efficient quality control workflows on the platform that can compile the opinions of several clinicians per annotation case, all while dramatically reducing time spent on project management.

Its API also helps machine learning engineers integrate with their cloud and clinical data stores, for example, AWS or hospital enterprise PACS servers. The APIs are used to build ML data pipelines.

RedBrick AI launched in 2021 by CEO and co-founder Shivam Sharma, and CTO and co-founder Derek Lukacs. Both Shivam and Derek previously worked on SpaceX's Hyperloop technology, and participated in the SpaceX Hyperloop Pod Competition. Shivam has a background in aerospace engineering and computer science from University of Michigan, while Derek holds a Bachelors and Masters in aerospace engineering from the University of Michigan.


About RedBrick AI

Teams building medical imaging AI use RedBrick AI to rapidly and collaboratively build high-quality training datasets. The RedBrick AI SaaS platform offers high-performance web annotation tools for 2D and 3D data to give experts access to specialized tooling right from their browsers. The RedBrick configurable workflow system helps teams build robust and scalable quality assurance processes. RedBrick AI offers a suite of APIs to help developers consume the annotations being created, and integrate with MLOps.


For more information on RedBrick AI, visit


About Surge

Surge is Sequoia Capital India and Southeast Asia's rapid-scale up program. Surge combines up to USD 3 Mn of seed capital with company-building workshops, a global curriculum and support from a community of exceptional mentors and founders. The program's goal is to supercharge early-stage startups in India and Southeast Asia and give founders an unfair advantage, right out of the gate.


For more information on Surge, visit


About Sequoia Capital India and Southeast Asia

Sequoia helps daring founders build legendary companies, from idea to IPO to beyond.


Sequoia Capital India and Sequoia Capital Southeast Asia actively partner with founders from a wide range of companies, across categories, including BYJUs, CRED, Druva, Five Star Finance, Freshworks, GoTo, Groww, Kopi Kenangan, Mamaearth, Pine Labs, Polygon, Razorpay, Truecaller, Zomato and more.


We spur founders to push the boundaries of what's possible. In partnering with Sequoia, startups benefit with over 50 years of tribal knowledge and lessons learned working with companies like Airbnb, Alibaba, Apple, Dropbox, Google, LinkedIn and Stripe early on.


From the beginning universities, endowments, and other non profits have been the backbone of our investor base which means founders' accomplishments make a meaningful difference. For more information on Sequoia's work in India and Southeast Asia visit sequoiacap.com/India and sequoiacap.com/sea.


MENAFN24112022005728012573ID1105226404


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.